2024
DOI: 10.1016/j.hest.2023.10.005
|View full text |Cite
|
Sign up to set email alerts
|

Could clazosentan, first approved in Japan, improve neurological prognosis after subarachnoid hemorrhage in combination with modified water-electrolyte management?

Eiji Shikata,
Izumi Yamaguchi,
Masaaki Korai
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
references
References 39 publications
0
0
0
Order By: Relevance